πŸ‡ΊπŸ‡Έ FDA
Patent

US 12419831

Hydrocortisone oral liquid formulations

granted A61KA61K31/573A61K47/10

Quick answer

US patent 12419831 (Hydrocortisone oral liquid formulations) held by Eton Pharmaceuticals, Inc. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Eton Pharmaceuticals, Inc.
Grant date
Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/573, A61K47/10, A61K47/14, A61K47/183